IDO2 and cancer: TME consists of myeloid suppressor cells, tumor-associated macrophages and Treg-secreting cytokines that inhibit the anti-cancer response, and soluble immunosuppressive factors (transforming growth factor beta (TGF-β), interleukin 4, indoleamine 2,3-dioxygenase) [122].